First Time Loading...

Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 50.55 USD 0.36% Market Closed
Updated: Apr 27, 2024
Section:
 

Relative Value

The Relative Value of one GMED stock under the Base Case scenario is 100.74 USD. Compared to the current market price of 50.55 USD, Globus Medical Inc is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMED Relative Value
Base Case
100.74 USD
Undervaluation 50%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.4
P/S
P/S
Price to Sales
4.4
vs History
98
vs Industry
29
Median 3Y
6.7
Median 5Y
6.6
Industry
2.4
Forward
2.7
More Details
56.1
P/E
P/E
Price to Earnings
56.1
vs History
17
vs Industry
8
Median 3Y
43
Median 5Y
41
Industry
23.2
Forward
18.5
More Details
28.3
P/OCF
P/OCF
Price to OCF
28.3
vs History
66
vs Industry
14
Median 3Y
30.4
Median 5Y
30.1
Industry
15.5
More Details
41.7
P/FCFE
P/FCFE
Price to FCFE
41.7
vs History
65
vs Industry
15
Median 3Y
43.7
Median 5Y
45
Industry
23.5
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
93
vs Industry
47
Median 3Y
3.7
Median 5Y
3.7
Industry
2.2
More Details
4.3
EV/S
EV/S
Enterprise Value to Sales
4.3
vs History
98
vs Industry
27
Median 3Y
6.2
Median 5Y
6.2
Industry
2.5
Forward
2.7
More Details
6.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.7
vs History
87
vs Industry
34
Median 3Y
8.3
Median 5Y
8
Industry
5.2
More Details
19.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.6
vs History
76
vs Industry
17
Median 3Y
21.1
Median 5Y
21.7
Industry
12.5
Forward
9.2
More Details
33.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
33.6
vs History
34
vs Industry
12
Median 3Y
32.1
Median 5Y
30.8
Industry
17.2
Forward
14.1
More Details
27.9
EV/OCF
EV/OCF
Enterprise Value to OCF
27.9
vs History
53
vs Industry
15
Median 3Y
29
Median 5Y
28.5
Industry
15.1
More Details
41.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
41.1
vs History
61
vs Industry
13
Median 3Y
41.3
Median 5Y
43.1
Industry
19.7
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
93
vs Industry
47
Median 3Y
4
Median 5Y
4.1
Industry
2
More Details

Multiples Across Competitors

GMED Competitors Multiples
Globus Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Globus Medical Inc
NYSE:GMED
6.9B USD 4.4 56.1 19.6 33.6
US
Abbott Laboratories
NYSE:ABT
186.5B USD 4.6 33.1 19.5 29
US
Intuitive Surgical Inc
NASDAQ:ISRG
133.1B USD 18.2 67 54.9 68.9
US
Stryker Corp
NYSE:SYK
127.6B USD 6.2 40.3 25.1 31.1
US
Boston Scientific Corp
NYSE:BSX
107.2B USD 7.5 68.3 31.7 47.3
IE
Medtronic PLC
NYSE:MDT
106B USD 3.3 25.2 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
66.9B USD 3.4 54.9 18.4 38.9
DE
Siemens Healthineers AG
XETRA:SHL
59.1B EUR 2.7 38.9 18.6 31.4
US
Edwards Lifesciences Corp
NYSE:EW
52B USD 8.7 37 26.8 29
US
Dexcom Inc
NASDAQ:DXCM
47.9B USD 13.2 88.5 59.6 77.6
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
349.3B CNY 10.2 30.8 26.7 26.7

See Also

Summary
GMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
GMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GMED stock valuation using valuation multiples.
Wall Street Estimates
GMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.